Oral and parenteral drug delivery poses poor patient compliance due to several reasons, thus transdermal drug delivery takes up ahead over these and is of high interest for the pharmaceutical researchers inspite of the big disadvantage caused by stratum corneum which interferes with the bioavailability of the drug. So inorder to overcome this hurdle, carrier systems like novel vesicular drug delivery has become popular. Transferosomes is one among them which has got a great advantage of deformability. It can deform upto 5-10 times less than their original size. This property of high deformation leads to delivery of drug with better permeation into intact vesicles. Low as well as high molecular weight drugs can be formulated as transferosomes due to this property. Thus, to conclude in future transferosomes can be developed in many drugs to increase their bioavailability.
